Johan Luthman appointed EVP, Research & Development

Johan is a proven and passionate leader with 28 years of experience in neuroscience and global pharmaceutical research and development. Johan will take up his new position on 1 March 2019.

It is with great pleasure that we today announce Johan Luthman as Lundbeck's new Executive Vice President for Research and Development.

Johan brings 28 years of experience in pharmaceutical research and development in a range of different brain diseases as well as other disease areas. Furthermore, he possesses a considerable R&D bandwidth, from target and drug discovery throughout clinical development and lifecycle management. 

Johan is born in Sweden and has a PhD from Karolinska Institute in histology and neurobiology. Through his career, Johan has had several positions in Sweden, Switzerland and USA working for AstraZeneca, Merck Serona, Geneuro, Merck & Co and in his latest position as SVP & Head of Clinical Development at EISAI. 

 

Cookie Policy
You have chosen to leave www.lundbeck.com. Lundbeck does not have any responsibility for the content provided by other websites. Click "OK" to continue or "Cancel" to remain on www.lundbeck.com.